Contact
Please use this form to send email to PR contact of this press release:
Opiant Pharmaceuticals, Inc. Licenses Aegis Therapeutics’ Intravail® Drug Delivery Technology
TO:
Please use this form to send email to PR contact of this press release:
Opiant Pharmaceuticals, Inc. Licenses Aegis Therapeutics’ Intravail® Drug Delivery Technology
TO: